Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants

NCT02833831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALS-008176
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Janssen Research & Development, LLC